NCT04198766 2025-12-18Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)Inhibrx Biosciences, IncPhase 1/2 Active not recruiting296 enrolled
NCT04999761 2024-09-25AB122 Platform StudyTaiho Pharmaceutical Co., Ltd.Phase 1 Recruiting917 enrolled
NCT02897375 2023-10-10Palbociclib With Cisplatin or Carboplatin in Advanced Solid TumorsEmory UniversityPhase 1 Completed71 enrolled
NCT01047007 2023-09-21A Dose Escalation Study of Adavosertib(MK1775) in Combination With 5-FU or 5-FU/CDDP in Patients With Advanced Solid Tumor (1775-005Merck Sharp & Dohme LLCPhase 1 Terminated11 enrolled 10 charts
NCT00703638 2017-11-29Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid TumorsMasonic Cancer Center, University of MinnesotaPhase 1 Completed16 enrolled